EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status

Matteo Lambertini iD, Eva Blondeaux iD, Loredana M Tomasello, Elisa Agostinetto iD, Anne-Sophie Hamy iD, Hee Jeong Kim iD, Maria Alice Franzoi iD, Rinat Bernstein-Molho, Florentine Hilbers iD, Katarzyna Pogoda iD, Hans Wildiers iD, Jyoti Bajpai iD und 27 weitere

Journal of Clinical Oncology · 10.05.2025 · 43 (14) · 1706-1719

DOI: 10.1200/jco-24-01334 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.05.2025. Verfasst von Matteo Lambertini und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Germ-Line Mutation, BRCA2 Protein, BRCA1 Protein. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To investigate the clinical behavior of breast cancer in young BRCA carriers according to the specific BRCA gene ( BRCA1 v BRCA2 ) and the association of the timing of genetic testing (before v at diagnosis) with prognosis. METHODS This was an international, multicenter, hospital-based, retrospective cohort study that included 4,752 patients harboring germline pathogenic/likely pathogenic variants (PVs) in BRCA1 or BRCA2 , who were diagnosed with stage I-III invasive breast cancer at 40 years or younger between January 2000 and December 2020 in 78 centers worldwide (ClinicalTrials.gov identifier: NCT03673306 ). RESULTS Compared with BRCA2 carriers (n = 1,683), BRCA1 carriers (n = 3,069) had more frequently hormone receptor–negative (74.4% v 15.5%) and high-grade (77.5% v 49.1%) tumors. Similar outcomes were observed in BRCA1 and BRCA2 carriers but with a different pattern and risk of disease-free survival events over time. Compared with patients tested for BRCA at diagnosis (ie, between 2 months before and up to 6 months after diagnosis; n = 1,671), those tested before diagnosis (ie, any time up to 2 months before diagnosis; n = 411) had smaller tumors (T1: 61.3% v 32.4%), less nodal involvement (N0: 65.9% v 50.8%), less frequently received chemotherapy (84.4% v 92.9%), and axillary dissection (37.5% v 47.4%). Patients tested before diagnosis had better overall survival (OS; unadjusted hazard ratio [HR], 0.61 [95% CI, 0.40 to 0.92]); however, this result lost statistical significance after adjustment for potential confounders including tumor stage (adjusted HR, 0.74 [95% CI, 0.47 to 1.15]). CONCLUSION This global study provides evidence on the different clinical behavior of breast cancer in young BRCA1 and BRCA2 carriers. Identifying a BRCA PV in healthy individuals was associated with earlier-stage breast cancer diagnosis and lower treatment burden, as well as better unadjusted OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGerm-Line MutationBRCA2 ProteinBRCA1 ProteinHumansFemaleAdultRetrospective StudiesGenetic TestingHeterozygoteGenetic Predisposition to DiseasePrognosisYoung Adult

Substanzen

BRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBRCA1 Protein

Autor:innen und Institutionen

  • Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy.
  • Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Section of Medical Oncology, Department of Precision Medicine in Medical, Surgical and Clinical Care (Me.Pre.C.C), University of Palermo, Palermo, Italy.
  • Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.
  • Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France.

ORCID-Profile: Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Maria Alice Franzoi, Florentine Hilbers, Katarzyna Pogoda, Hans Wildiers, Jyoti Bajpai, Michail Ignatiadis, Halle C F Moore, Ann H Partridge, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Carmen Criscitiello, Alberta Ferrari, Robert Fruscio, Wanda Cui, Stephanie M Wong, Claudio Vernieri, Kathryn J Ruddy, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Cynthia Villarreal-Garza, Laura De Marchis, Fabio Puglisi, Kenny A Rodriguez-Wallberg, Luca Livraghi, Marco Bruzzone, Luca Boni, Judith Balmaña

Förderung

  • NCI NIH HHS

Zitieren

APA

Lambertini, M., Blondeaux, E., Tomasello, L. M., Agostinetto, E., Hamy, A. S., Kim, H. J., Franzoi, M. A., Bernstein-Molho, R., Hilbers, F., Pogoda, K., Wildiers, H., Bajpai, J., Ignatiadis, M., Moore, H. C. F., Partridge, A. H., Phillips, K. A., Toss, A., Rousset-Jablonski, C., Criscitiello, C., …, & Balmaña, J. (2025). Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status. Journal of Clinical Oncology, 43(14), 1706-1719. https://doi.org/10.1200/jco-24-01334

Vancouver

Lambertini M, Blondeaux E, Tomasello LM, Agostinetto E, Hamy AS, Kim HJ, et al. Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status. Journal of Clinical Oncology. 2025;43(14):1706-1719. doi:10.1200/jco-24-01334

BibTeX
@article{Lambertini2025,
  author = {Lambertini, Matteo and Blondeaux, Eva and Tomasello, Loredana M and Agostinetto, Elisa and Hamy, Anne-Sophie and Kim, Hee Jeong and Franzoi, Maria Alice and Bernstein-Molho, Rinat and Hilbers, Florentine and Pogoda, Katarzyna and Wildiers, Hans and Bajpai, Jyoti and Ignatiadis, Michail and Moore, Halle C F and Partridge, Ann H and Phillips, Kelly-Anne and Toss, Angela and Rousset-Jablonski, Christine and Criscitiello, Carmen and Renaud, Tiphaine and Ferrari, Alberta and Paluch-Shimon, Shani and Fruscio, Robert and Cui, Wanda and Wong, Stephanie M and Vernieri, Claudio and Ruddy, Kathryn J and Dieci, Maria Vittoria and Matikas, Alexios and Rozenblit, Mariya and Villarreal-Garza, Cynthia and De Marchis, Laura and Puglisi, Fabio and Rodriguez-Wallberg, Kenny A and Duhoux, Francois P and Livraghi, Luca and Bruzzone, Marco and Boni, Luca and Balmaña, Judith},
  title = {Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  volume = {43},
  number = {14},
  pages = {1706--1719},
  doi = {10.1200/jco-24-01334}
}
Kostenlos starten →